TENAX THERAPEUTICS, INC. Earnings Per Share (Basic)
TENAX THERAPEUTICS, INC. (TENX) reported Earnings Per Share (Basic) of -$0.35 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-07-31
- TENAX THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.35.
- TENAX THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.35.
- TENAX THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.40.
- TENAX THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.27.
- TENAX THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$1.34.
- TENAX THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$1.15.
- TENAX THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$31.04.
- TENAX THERAPEUTICS, INC. earnings per share, basic for fiscal 2015 was -$0.50.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 8 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.35 10-Q · filed 2026-07-31 | -$0.70 10-Q · filed 2026-07-31 | |||||||
| 2026-03-31 | -$0.35 10-Q · filed 2026-05-12 | ||||||||
| 2025-12-31 | -$1.34 10-K · filed 2026-03-10 | ||||||||
| 2025-09-30 | -$0.40 10-Q · filed 2025-11-12 | -$0.96 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | -$0.27 10-Q · filed 2026-07-31 | -$0.56 10-Q · filed 2026-07-31 | |||||||
| 2025-03-31 | -$0.28 10-Q · filed 2026-05-12 | ||||||||
| 2024-12-31 | -$1.15 10-K · filed 2026-03-10 | ||||||||
| 2024-09-30 | -$0.19 10-Q · filed 2025-11-12 | -$1.37 10-Q · filed 2025-11-12 | |||||||
| 2024-06-30 | -$1.83 10-Q · filed 2025-08-13 | -$4.65 10-Q · filed 2025-08-13 | |||||||
| 2024-03-31 | -$3.12 10-Q · filed 2025-05-14 | ||||||||
| 2023-12-31 | -$31.04 10-K · filed 2025-03-25 | ||||||||
| 2015-12-31 | -$0.36 10-KT · filed 2016-03-14 | ||||||||
| 2015-04-30 | $0.82 derived: net income ÷ weighted average shares · filed 2017-03-16 | $0.72 derived: net income ÷ weighted average shares · filed 2017-03-16 | $0.87 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$0.50 10-KT · filed 2016-03-14 | |||||
| 2015-01-31 | -$0.10 10-Q · filed 2015-03-17 | $0.04 derived: net income ÷ weighted average shares · filed 2015-03-17 | -$0.32 10-Q · filed 2015-03-17 | $1.68 derived: net income ÷ weighted average shares · filed 2017-03-16 | |||||
| 2014-10-31 | -$0.14 10-Q · filed 2014-12-15 | -$0.22 10-Q · filed 2014-12-15 | $1.84 derived: net income ÷ weighted average shares · filed 2017-03-16 | $1.95 derived: net income ÷ weighted average shares · filed 2017-03-16 | |||||
| 2014-07-31 | -$0.08 10-Q · filed 2014-09-15 | $1.78 derived: net income ÷ weighted average shares · filed 2017-03-16 | $1.96 derived: net income ÷ weighted average shares · filed 2017-03-16 | $2.80 derived: net income ÷ weighted average shares · filed 2017-03-16 | |||||
| 2014-04-30 | $2.01 derived: net income ÷ weighted average shares · filed 2017-03-16 | $2.36 derived: net income ÷ weighted average shares · filed 2017-03-16 | $3.57 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$2.71 10-KT · filed 2016-03-14 | |||||
| 2014-01-31 | -$0.43 10-Q · filed 2015-03-17 | $0.22 derived: net income ÷ weighted average shares · filed 2015-03-17 | -$2.56 10-Q · filed 2015-03-17 | $1.84 derived: net income ÷ weighted average shares · filed 2016-03-14 | |||||
| 2013-10-31 | -$1.23 10-Q · filed 2014-12-15 | -$2.94 10-Q · filed 2014-12-15 | $4.48 derived: net income ÷ weighted average shares · filed 2016-03-14 | $5.95 derived: net income ÷ weighted average shares · filed 2016-03-14 | |||||
| 2013-07-31 | -$2.06 10-Q · filed 2014-09-15 | $3.64 derived: net income ÷ weighted average shares · filed 2016-03-14 | $5.14 derived: net income ÷ weighted average shares · filed 2016-03-14 | $6.19 derived: net income ÷ weighted average shares · filed 2016-03-14 | |||||
| 2013-04-30 | $1.54 derived: net income ÷ weighted average shares · filed 2016-03-14 | $3.00 derived: net income ÷ weighted average shares · filed 2016-03-14 | $4.00 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$6.29 10-KT · filed 2016-03-14 | |||||
| 2013-01-31 | -$1.45 10-Q · filed 2014-03-17 | -$0.07 10-Q · filed 2013-03-18 | $2.43 derived: net income ÷ weighted average shares · filed 2014-03-17 | -$4.75 10-Q · filed 2014-03-17 | -$0.24 10-Q · filed 2013-03-18 | ||||
| 2012-10-31 | -$0.97 10-Q · filed 2013-12-17 | -$0.05 10-Q · filed 2012-12-14 | -$3.30 10-Q · filed 2013-12-17 | -$0.17 10-Q · filed 2012-12-14 | |||||
| 2012-07-31 | -$2.38 10-Q · filed 2013-09-17 | -$0.12 10-Q · filed 2012-09-19 | |||||||
| 2012-04-30 | -$12.12 10-K · filed 2013-06-26 | -$0.61 10-K · filed 2012-07-25 | |||||||
| 2012-01-31 | -$0.26 10-Q · filed 2013-03-18 | -$0.53 10-Q · filed 2013-03-18 | |||||||
| 2011-10-31 | -$0.12 10-Q · filed 2012-12-14 | -$0.25 10-Q · filed 2012-12-14 | |||||||
| 2011-07-31 | -$0.12 10-Q · filed 2012-09-19 | ||||||||
| 2011-04-30 | -$0.45 10-K · filed 2012-07-25 | ||||||||
| 2011-01-31 | -$0.11 10-Q · filed 2012-03-15 | -$0.33 10-Q · filed 2012-03-15 | |||||||
| 2010-10-31 | -$0.09 10-Q · filed 2011-12-15 | -$0.22 10-Q · filed 2011-12-15 | |||||||
| 2010-07-31 | -$0.13 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |